Latest transplantation Stories

A new study from Boston University School of Medicine (BUSM) shows that tissues derived from induced pluripotent stem (iPS) cells in an experimental model were not rejected when transplanted back into genetically identical recipients. The study, published online in Cell Stem Cell, demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune...

Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The results of the study were released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. "There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," said study author Stefania Corti, MD, PhD, with the...

SALT LAKE CITY, Jan. 8, 2013 /PRNewswire/ -- Remedy Informatics, Inc., the leading provider of registries for blood and marrow transplantation centres around the world, announced that the European Group for Blood and Marrow Transplantation (EBMT) has selected Remedy's Mosaic(TM) Platform as the technology solution for EBMT's Registry Upgrade Project. (Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO) EBMT is upgrading its current EBMT Registry to meet the evolving...

HORSHOLM, Denmark, Jan. 3, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S today is announcing that the LCP-Tacro Phase III clinical trial in stable kidney transplant patients, the 3001 study, has been published online in the American Journal of Transplantation. The article reports on the randomized, controlled, multicenter Phase III trial, which demonstrated that LCP-Tacro dosed once-daily was not inferior to the current leading transplant drug, Prograf(®), dosed twice-daily....

DENVER, Dec. 12, 2012 /PRNewswire/ -- Donor Alliance, the federally-designated, non-profit organ procurement organization and American Association of Tissue Banks (AATB) accredited tissue bank serving Colorado and most of Wyoming today announced its sponsorship of a float rider from Colorado aboard the annual Donate Life float in the Tournament of Roses Parade®. Peter Lang of Golden was just 16-years-old when his sister Perri Lang lost her life following a car accident, becoming...

Studies of stem cell biology and transplant approaches presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) illustrate how the use of advanced modeling techniques is optimizing stem cells to treat patients with blood disorders, as well as the potential of enhanced treatment strategies to improve the success rate of hematopoietic stem cell (HSC) transplantation for these patients. Hematopoietic stem cell transplantation is effectively used today as a form...

ROCKVILLE, Md., Dec. 10, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the International Symposium on ALS/MND in Chicago, sponsored by the Motor Neurone Disease Association. In a Thursday presentation, "RESULTS OF PHASE 1 TRIAL OF SPINAL CORD...

HORSHOLM, Denmark, Dec. 6, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced results of a preliminary analysis from the first 16 patients in its Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO) clinical trial. Results from the first 16 patients demonstrated a trend toward a reduction in tremor following the switch from twice-daily tacrolimus to once-daily LCP-Tacro. "Tremor is a common side effect of tacrolimus administration...

SEATTLE, Dec. 5, 2012 /PRNewswire/ -- The 37(th) annual Hutch Holiday Gala raised more than $4.8 million for research at Fred Hutchinson Cancer Research Center. The black-tie event, held Saturday, Dec. 1 at the Sheraton Seattle Hotel, rallied private support to accelerate lifesaving discoveries and new treatments in transplantation research. Hosted by the Grace Heffernan Arnold Guild and the Hutch Holiday Gala board of directors, the Gala featured live and silent auctions, an...

Pharmacological stress echo identifies donor hearts that would historically have been rejected Hearts previously rejected due to donors' age or other risk factors can now be declared viable for transplantation using pharmacological stress echo, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Tonino Bombardini from Pisa, Italy. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of...